631 related articles for article (PubMed ID: 25108173)
1. Nitazoxanide: a first-in-class broad-spectrum antiviral agent.
Rossignol JF
Antiviral Res; 2014 Oct; 110():94-103. PubMed ID: 25108173
[TBL] [Abstract][Full Text] [Related]
2. Development of Novel Anti-influenza Thiazolides with Relatively Broad-Spectrum Antiviral Potentials.
Zhao L; Yan Y; Dai Q; Li X; Xu K; Zou G; Yang K; Li W; Guo X; Yang J; Li Y; Xia Q; Cao R; Zhong W
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32312780
[TBL] [Abstract][Full Text] [Related]
3. Thiazolides: a new class of antiviral drugs.
Rossignol JF
Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):667-74. PubMed ID: 19442032
[TBL] [Abstract][Full Text] [Related]
4. Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level.
Rossignol JF; La Frazia S; Chiappa L; Ciucci A; Santoro MG
J Biol Chem; 2009 Oct; 284(43):29798-808. PubMed ID: 19638339
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of salicylamide derivatives for combating viral infections.
Xu J; Xue Y; Bolinger AA; Li J; Zhou M; Chen H; Li H; Zhou J
Med Res Rev; 2023 Jul; 43(4):897-931. PubMed ID: 36905090
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro.
Belardo G; Cenciarelli O; La Frazia S; Rossignol JF; Santoro MG
Antimicrob Agents Chemother; 2015 Feb; 59(2):1061-9. PubMed ID: 25451059
[TBL] [Abstract][Full Text] [Related]
7. Thiazolides, a new class of antiviral agents effective against rotavirus infection, target viral morphogenesis, inhibiting viroplasm formation.
La Frazia S; Ciucci A; Arnoldi F; Coira M; Gianferretti P; Angelini M; Belardo G; Burrone OR; Rossignol JF; Santoro MG
J Virol; 2013 Oct; 87(20):11096-106. PubMed ID: 23926336
[TBL] [Abstract][Full Text] [Related]
8. Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir.
Tilmanis D; Koszalka P; Barr IG; Rossignol JF; Mifsud E; Hurt AC
Antiviral Res; 2020 Aug; 180():104851. PubMed ID: 32544408
[TBL] [Abstract][Full Text] [Related]
9. Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus.
Rossignol JF
J Infect Public Health; 2016; 9(3):227-30. PubMed ID: 27095301
[TBL] [Abstract][Full Text] [Related]
10. Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication.
Korba BE; Montero AB; Farrar K; Gaye K; Mukerjee S; Ayers MS; Rossignol JF
Antiviral Res; 2008 Jan; 77(1):56-63. PubMed ID: 17888524
[TBL] [Abstract][Full Text] [Related]
11. The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide.
Tilmanis D; van Baalen C; Oh DY; Rossignol JF; Hurt AC
Antiviral Res; 2017 Nov; 147():142-148. PubMed ID: 28986103
[TBL] [Abstract][Full Text] [Related]
12. Nitazoxanide inhibits paramyxovirus replication by targeting the Fusion protein folding: role of glycoprotein-specific thiol oxidoreductase ERp57.
Piacentini S; La Frazia S; Riccio A; Pedersen JZ; Topai A; Nicolotti O; Rossignol JF; Santoro MG
Sci Rep; 2018 Jul; 8(1):10425. PubMed ID: 29992955
[TBL] [Abstract][Full Text] [Related]
13. Nitazoxanide Inhibits Human Norovirus Replication and Synergizes with Ribavirin by Activation of Cellular Antiviral Response.
Dang W; Xu L; Ma B; Chen S; Yin Y; Chang KO; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104275
[TBL] [Abstract][Full Text] [Related]
14. Antiviral drugs for viruses other than human immunodeficiency virus.
Razonable RR
Mayo Clin Proc; 2011 Oct; 86(10):1009-26. PubMed ID: 21964179
[TBL] [Abstract][Full Text] [Related]
15. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
16. Second-generation nitazoxanide derivatives: thiazolides are effective inhibitors of the influenza A virus.
Stachulski AV; Santoro MG; Piacentini S; Belardo G; Frazia S; Pidathala C; Row EC; Berry NG; Iqbal M; Allman SA; Semple JE; Eklov BM; O'Neill PM; Rossignol JF
Future Med Chem; 2018 Apr; 10(8):851-862. PubMed ID: 29629834
[TBL] [Abstract][Full Text] [Related]
17. The second-generation thiazolide haloxanide is a potent inhibitor of avian influenza virus replication.
La Frazia S; Piacentini S; Riccio A; Rossignol JF; Santoro MG
Antiviral Res; 2018 Sep; 157():159-168. PubMed ID: 29908209
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pre-clinical studies of new amino-acid ester thiazolide prodrugs.
Stachulski AV; Swift K; Cooper M; Reynolds S; Norton D; Slonecker SD; Rossignol JF
Eur J Med Chem; 2017 Jan; 126():154-159. PubMed ID: 27750149
[TBL] [Abstract][Full Text] [Related]
19. Oseltamivir: a review of its use in influenza.
McClellan K; Perry CM
Drugs; 2001; 61(2):263-83. PubMed ID: 11270942
[TBL] [Abstract][Full Text] [Related]
20. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M
Front Immunol; 2019; 10():60. PubMed ID: 30761132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
